Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity

Metabolism: Clinical and Experimental

Volumn 65, Issue 5, 2016, Pages 655-666

  Walle, Paula ^a   Takkunen, Markus ^a   Männistö, Ville ^b   Vaittinen, Maija ^a   Lankinen, Maria ^a   Kärjä, Vesa ^b   Käkelä, Pirjo ^b   Ågren, Jyrki ^a   Tiainen, Mika ^a   Schwab, Ursula ^a,b   Kuusisto, Johanna ^b   Laakso, Markku ^b   Pihlajamäki, Jussi ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Fatty acid desaturase; Hepatic mRNA expression; Liver fatty acid composition; Non alcoholic fatty liver disease; Serum fatty acid composition

Indexed keywords

ACYL COENZYME A DESATURASE 1; ALANINE AMINOTRANSFERASE; CHOLESTEROL ESTER; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYRISTIC ACID; PALMITOLEIC ACID; TRIACYLGLYCEROL; ACYL COENZYME A DESATURASE; ISOENZYME;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; BARIATRIC SURGERY; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; LIPID COMPOSITION; LIVER BIOPSY; LIVER HISTOLOGY; LIVER METABOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL ETHICS; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; STOMACH BYPASS; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; COHORT ANALYSIS; COMPLICATION; ENZYMOLOGY; FATTY LIVER; FINLAND; GENE EXPRESSION REGULATION; GENETICS; LIVER; METABOLISM; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY, MORBID; PATHOLOGY; RISK;

ADULT; BODY MASS INDEX; CHOLESTEROL ESTERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FATTY ACID DESATURASES; FATTY ACIDS; FATTY LIVER; FEMALE; FINLAND; GASTRIC BYPASS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; ISOENZYMES; LIVER; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY, MORBID; RISK; TRIGLYCERIDES;

EID: 84962019076     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2016.01.011     Document Type: Article

References (60)

1. G. Vernon, A. Baranova, and Z.M. Younossi Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults Aliment Pharmacol Ther 34 2011 274 285
2. B.A. Neuschwander-Tetri, and S.H. Caldwell Nonalcoholic steatohepatitis: summary of an AASLD single topic conference Hepatology 37 2003 1202 1219
3. M.J. Contos, and A.J. Sanyal The clinicopathologic spectrum and management of nonalcoholic fatty liver disease Adv Anat Pathol 9 2002 37 51
4. M. Ekstedt, L.E. Franzen, U.L. Mathiesen, L. Thorelius, M. Holmqvist, G. Bodemar, and et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes Hepatology 44 2006 865 873
5. N. Rafiq, C. Bai, Y. Fang, M. Srishord, A. McCullough, T. Gramlich, and et al. Long-term follow-up of patients with nonalcoholic fatty liver Clin Gastroenterol Hepatol 7 2009 234 238
6. J.D. Browning, and J.D. Horton Molecular mediators of hepatic steatosis and liver injury J Clin Invest 114 2004 147 152
7. A.J. Sanyal, C. Campbell-Sargent, F. Mirshahi, W.B. Rizzo, M.J. Contos, R.K. Sterling, and et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities Gastroenterology 120 2001 1183 1192
8. A.R. Saltiel, and C.R. Kahn Insulin signalling and the regulation of glucose and lipid metabolism Nature 414 2001 799 806
9. R.A. Egnatchik, A.K. Leamy, Y. Noguchi, M. Shiota, and J.D. Young Palmitate-induced activation of mitochondrial metabolism promotes oxidative stress and apoptosis in H4IIEC3 rat hepatocytes Metabolism 63 2014 283 295
10. S. Pereira, D.M. Breen, A.E. Naassan, P.Y. Wang, H. Uchino, I.G. Fantus, and et al. In vivo effects of polyunsaturated, monounsaturated, and saturated fatty acids on hepatic and peripheral insulin sensitivity Metabolism 64 2015 315 322
11. A. Wree, M. Schlattjan, L.P. Bechmann, T. Claudel, J.P. Sowa, T. Stojakovic, and et al. Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients Metabolism 63 2014 1542 1552
12. J. Araya, R. Rodrigo, L.A. Videla, L. Thielemann, M. Orellana, P. Pettinelli, and et al. Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease Clin Sci (Lond) 106 2004 635 643
13. I.T. de Almeida, H. Cortez-Pinto, G. Fidalgo, D. Rodrigues, and M.E. Camilo Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis Clin Nutr 21 2002 219 223
14. P. Puri, R.A. Baillie, M.M. Wiest, F. Mirshahi, J. Choudhury, O. Cheung, and et al. A lipidomic analysis of nonalcoholic fatty liver disease Hepatology 46 2007 1081 1090
15. P. Puri, M.M. Wiest, O. Cheung, F. Mirshahi, C. Sargeant, H.K. Min, and et al. The plasma lipidomic signature of nonalcoholic steatohepatitis Hepatology 50 2009 1827 1838
16. K. Yamada, E. Mizukoshi, H. Sunagozaka, K. Arai, T. Yamashita, Y. Takeshita, and et al. Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis Liver Int 35 2015 582 590
17. A.E. Feldstein, N.W. Werneburg, A. Canbay, M.E. Guicciardi, S.F. Bronk, R. Rydzewski, and et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway Hepatology 40 2004 185 194
18. Z.Z. Li, M. Berk, T.M. McIntyre, and A.E. Feldstein Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase J Biol Chem 284 2009 5637 5644
19. K. Anjani, M. Lhomme, N. Sokolovska, C. Poitou, J. Aron-Wisnewsky, J.L. Bouillot, and et al. Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity J Hepatol 62 2015 905 912
20. B.M. Arendt, E.M. Comelli, D.W. Ma, W. Lou, A. Teterina, T. Kim, and et al. Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids Hepatology 61 2015 1565 1578
21. T. Auguet, A. Berlanga, E. Guiu-Jurado, S. Martinez, J.A. Porras, G. Aragones, and et al. Altered fatty acid metabolism-related gene expression in liver from morbidly obese women with non-alcoholic fatty liver disease Int J Mol Sci 15 2014 22173 22187
22. J. Hyysalo, V.T. Mannisto, Y. Zhou, J. Arola, V. Karja, M. Leivonen, and et al. A population-based study on the prevalence of NASH using scores validated against liver histology J Hepatol 60 2014 839 846
23. V.T. Mannisto, M. Simonen, J. Hyysalo, P. Soininen, A.J. Kangas, D. Kaminska, and et al. Ketone body production is differentially altered in steatosis and non-alcoholic steatohepatitis in obese humans Liver Int 35 2015 1853 1861
24. J. Pihlajamaki, S. Gronlund, M. Simonen, P. Kakela, L. Moilanen, M. Paakkonen, and et al. Cholesterol absorption decreases after roux-en-Y gastric bypass but not after gastric banding Metabolism 59 2010 866 872
25. J. Pihlajamaki, T. Kuulasmaa, D. Kaminska, M. Simonen, V. Karja, S. Gronlund, and et al. Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans J Hepatol 56 2012 663 670
26. A. Stancakova, M. Javorsky, T. Kuulasmaa, S.M. Haffner, J. Kuusisto, and M. Laakso Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men Diabetes 58 2009 1212 1221
27. J.J. Agren, A. Julkunen, and I. Penttila Rapid separation of serum lipids for fatty acid analysis by a single aminopropyl column J Lipid Res 33 1992 1871 1876
28. T. Venalainen, U. Schwab, J. Agren, V. de Mello, V. Lindi, A.M. Eloranta, and et al. Cross-sectional associations of food consumption with plasma fatty acid composition and estimated desaturase activities in Finnish children Lipids 49 2014 467 479
29. V.T. Mannisto, M. Simonen, P. Soininen, M. Tiainen, A.J. Kangas, D. Kaminska, and et al. Lipoprotein subclass metabolism in nonalcoholic steatohepatitis J Lipid Res 55 2014 2676 2684
30. A. Peter, A. Cegan, S. Wagner, R. Lehmann, N. Stefan, A. Konigsrainer, and et al. Hepatic lipid composition and stearoyl-coenzyme a desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios Clin Chem 55 2009 2113 2120
31. E.M. Brunt, C.G. Janney, A.M. Di Bisceglie, B.A. Neuschwander-Tetri, and B.R. Bacon Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am J Gastroenterol 94 1999 2467 2474
32. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, O.W. Cummings, and et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
33. M.T. Nakamura, and T.Y. Nara Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases Annu Rev Nutr 24 2004 345 376
34. E. Warensjo, J. Sundstrom, B. Vessby, T. Cederholm, and U. Riserus Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study Am J Clin Nutr 88 2008 203 209
35. B. Vessby Dietary fat, fatty acid composition in plasma and the metabolic syndrome Curr Opin Lipidol 14 2003 15 19
36. E. Warensjo, M. Ohrvall, and B. Vessby Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and women Nutr Metab Cardiovasc Dis 16 2006 128 136
37. H. Park, G. Hasegawa, T. Shima, M. Fukui, N. Nakamura, K. Yamaguchi, and et al. The fatty acid composition of plasma cholesteryl esters and estimated desaturase activities in patients with nonalcoholic fatty liver disease and the effect of long-term ezetimibe therapy on these levels Clin Chim Acta 411 2010 1735 1740
38. B. Vessby, I.B. Gustafsson, S. Tengblad, M. Boberg, and A. Andersson Desaturation and elongation of fatty acids and insulin action Ann N Y Acad Sci 967 2002 183 195
39. J.M. Ntambi, and M. Miyazaki Regulation of stearoyl-CoA desaturases and role in metabolism Prog Lipid Res 43 2004 91 104
40. E. Warensjo, U. Riserus, and B. Vessby Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men Diabetologia 48 2005 1999 2005
41. F. Paillard, D. Catheline, F.L. Duff, M. Bouriel, Y. Deugnier, M. Pouchard, and et al. Plasma palmitoleic acid, a product of stearoyl-coA desaturase activity, is an independent marker of triglyceridemia and abdominal adiposity Nutr Metab Cardiovasc Dis 18 2008 436 440
42. E. Warensjo, M. Rosell, M.L. Hellenius, B. Vessby, U. De Faire, and U. Riserus Associations between estimated fatty acid desaturase activities in serum lipids and adipose tissue in humans: links to obesity and insulin resistance Lipids Health Dis 8 2009 [37-511X-8-37]
43. S. Jacobs, K. Schiller, E.H. Jansen, H. Boeing, M.B. Schulze, and J. Kroger Evaluation of various biomarkers as potential mediators of the association between Delta5 desaturase, Delta6 desaturase, and stearoyl-CoA desaturase activity and incident type 2 diabetes in the European prospective investigation into cancer and nutrition-Potsdam study Am J Clin Nutr 102 2015 155 164
44. A. Kotronen, T. Seppanen-Laakso, J. Westerbacka, T. Kiviluoto, J. Arola, A.L. Ruskeepaa, and et al. Comparison of lipid and fatty acid composition of the liver, subcutaneous and intra-abdominal adipose tissue, and serum Obesity (Silver Spring) 18 2010 937 944
45. K. Tomita, T. Teratani, H. Yokoyama, T. Suzuki, R. Irie, H. Ebinuma, and et al. Plasma free myristic acid proportion is a predictor of nonalcoholic steatohepatitis Dig Dis Sci 56 2011 3045 3052
46. L. Martinez, S. Torres, A. Baulies, C. Alarcon-Vila, M. Elena, G. Fabrias, and et al. Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis Oncotarget 2015
47. S. Joshi-Barve, S.S. Barve, K. Amancherla, L. Gobejishvili, D. Hill, M. Cave, and et al. Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes Hepatology 46 2007 823 830
48. M.F. Chong, L. Hodson, A.S. Bickerton, R. Roberts, M. Neville, F. Karpe, and et al. Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding Am J Clin Nutr 87 2008 817 823
49. J.E. Lambert, M.A. Ramos-Roman, J.D. Browning, and E.J. Parks Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease Gastroenterology 146 2014 726 735
50. K. Sevastianova, A. Santos, A. Kotronen, A. Hakkarainen, J. Makkonen, K. Silander, and et al. Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans Am J Clin Nutr 96 2012 727 734
51. G. Silbernagel, M. Kovarova, A. Cegan, J. Machann, F. Schick, R. Lehmann, and et al. High hepatic SCD1 activity is associated with low liver fat content in healthy subjects under a lipogenic diet J Clin Endocrinol Metab 97 2012 E2288 E2292
52. F. Ameer, L. Scandiuzzi, S. Hasnain, H. Kalbacher, and N. Zaidi De novo lipogenesis in health and disease Metabolism 63 2014 895 902
53. K.L. Donnelly, C.I. Smith, S.J. Schwarzenberg, J. Jessurun, M.D. Boldt, and E.J. Parks Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease J Clin Invest 115 2005 1343 1351
54. H. Bjermo, D. Iggman, J. Kullberg, I. Dahlman, L. Johansson, L. Persson, and et al. Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial Am J Clin Nutr 95 2012 1003 1012
55. M. Maximos, F. Bril, P. Portillo Sanchez, R. Lomonaco, B. Orsak, D. Biernacki, and et al. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease Hepatology 61 2015 153 160
56. A. Peter, A. Cegan, S. Wagner, M. Elcnerova, A. Konigsrainer, I. Konigsrainer, and et al. Relationships between hepatic stearoyl-CoA desaturase-1 activity and mRNA expression with liver fat content in humans Am J Physiol Endocrinol Metab 300 2011 E321 E326
57. L. Hodson, C.M. Skeaff, and B.A. Fielding Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake Prog Lipid Res 47 2008 348 380
58. H. Yki-Jarvinen Nutritional modulation of Non-alcoholic fatty liver disease and insulin resistance Nutrients 7 2015 9127 9138
59. M.C. Lewis, M.L. Phillips, J.P. Slavotinek, L. Kow, C.H. Thompson, and J. Toouli Change in liver size and fat content after treatment with optifast very low calorie diet Obes Surg 16 2006 697 701
60. B. Vessby, I.B. Gustafsson, J. Boberg, B. Karlstrom, H. Lithell, and I. Werner Substituting polyunsaturated for saturated fat as a single change in a Swedish diet: effects on serum lipoprotein metabolism and glucose tolerance in patients with hyperlipoproteinaemia Eur J Clin Invest 10 1980 193 202